A5101991439- Genetic Neurodegenerative Diseases
- Amyotrophic Lateral Sclerosis Research
- Nuclear Receptors and Signaling
- Pharmacological Effects and Toxicity Studies
- Disaster Response and Management
- Epilepsy research and treatment
- Intracerebral and Subarachnoid Hemorrhage Research
- Atrial Fibrillation Management and Outcomes
- Neurosurgical Procedures and Complications
- Emergency and Acute Care Studies
- Traumatic Brain Injury and Neurovascular Disturbances
- Peripheral Neuropathies and Disorders
- Venous Thromboembolism Diagnosis and Management
- Neurogenetic and Muscular Disorders Research
- Parkinson's Disease Mechanisms and Treatments
- Intracranial Aneurysms: Treatment and Complications
- Neurological disorders and treatments
- Neuroblastoma Research and Treatments
- Botulinum Toxin and Related Neurological Disorders
- Coenzyme Q10 studies and effects
- Infectious Encephalopathies and Encephalitis
McLaren Honda (United Kingdom)
2019
National Institute of Neurological Disorders and Stroke
2003
Johns Hopkins University
2003
Cleveland Clinic
2003
University of Illinois Chicago
1995
The University of Texas Health Science Center at San Antonio
1990
Background: Andexanet alfa is a modified recombinant inactive factor Xa (FXa) designed to reverse FXa inhibitors. ANNEXA-4 (Andexanet Alfa, Novel Antidote the Anticoagulation Effects of Factor Inhibitors) was multicenter, prospective, phase-3b/4, single-group cohort study that evaluated andexanet in patients with acute major bleeding. The results final analyses are presented. Methods: Patients bleeding within 18 hours inhibitor administration were enrolled. Co-primary end points anti-FXa...
Objective symptom monitoring of patients with Amyotrophic Lateral Sclerosis (ALS) has the potential to provide an important source information evaluate impact disease on aspects real-world functional capacity and activities daily living in home setting, providing useful objective outcome measures for clinical trials.This study aimed investigate feasibility a novel digital platform remote data collection multiple symptoms-physical activity, heart rate variability (HRV), speech...
The management of patients with a single, unprovoked seizure is controversial. likelihood recurrence after first has profound social, vocational, and emotional implications for the patient. issue whether or not to use anticonvulsant medication in these an important part this controversy may be substantially affected by true probability recurrence. last word about seizures following initial, yet written. It widely stated that only 30% adult who experience will subsequently develop recurrent...
<sec> <title>BACKGROUND</title> Objective symptom monitoring of patients with Amyotrophic Lateral Sclerosis (ALS) has the potential to provide an important source information evaluate impact disease on aspects real-world functional capacity and activities daily living in home setting, providing useful objective outcome measures for clinical trials. </sec> <title>OBJECTIVE</title> This study aimed investigate feasibility a novel digital platform remote data collection multiple...